Literature DB >> 23895191

An evolving role of piperazine moieties in drug design and discovery.

Rahul V Patel1, Se Won Park.   

Abstract

This article purposes to provide insights to piperazine based molecular designs that will facilitate drug discovery program in future. In our pursuit to summarize the reservoir of bioactive agents, and in line with the synthetic economy of new heterocycles, many new roles are being identified for the multiple biotargets of piperazine moieties. We mark out how series of different scaffolds provide an extensive range of various piperazine-based analogues displaying antimicrobial, antituberculosis, anticancer, antiviral and antimalarial activities. We believe that piperazine family of compounds, and their various co-components, highlight the existence of several potential leads for the furtherance of novel bioactive agents.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23895191     DOI: 10.2174/13895575113139990073

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  16 in total

1.  Discovery of novel N-aryl piperazine CXCR4 antagonists.

Authors:  Huanyu Zhao; Anthony R Prosser; Dennis C Liotta; Lawrence J Wilson
Journal:  Bioorg Med Chem Lett       Date:  2015-04-17       Impact factor: 2.823

2.  Photoredox-catalyzed Direct Reductive Amination of Aldehydes without an External Hydrogen/Hydride Source.

Authors:  Rauful Alam; Gary A Molander
Journal:  Org Lett       Date:  2018-04-13       Impact factor: 6.005

Review 3.  Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents.

Authors:  Haijun Chen; Yu Gao; Ailan Wang; Xiaobin Zhou; Yunquan Zheng; Jia Zhou
Journal:  Eur J Med Chem       Date:  2015-01-16       Impact factor: 6.514

4.  Incorporation of Privileged Structures into Bevirimat Can Improve Activity against Wild-Type and Bevirimat-Resistant HIV-1.

Authors:  Yu Zhao; Qiong Gu; Susan L Morris-Natschke; Chin-Ho Chen; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2016-09-22       Impact factor: 7.446

5.  Synthesis of N-Mannich bases of berberine linking piperazine moieties revealing anticancer and antioxidant effects.

Authors:  Bhupendra Mistry; Rahul V Patel; Young-Soo Keum; Doo Hwan Kim
Journal:  Saudi J Biol Sci       Date:  2015-09-05       Impact factor: 4.219

6.  Synthesis and Biological Evaluation of Novel Benzhydrylpiperazine-Coupled Nitrobenzenesulfonamide Hybrids.

Authors:  Vallabhaneni S Murthy; Yasinalli Tamboli; Vagolu Siva Krishna; Dharmarajan Sriram; Fang Xiong Zhang; Gerald W Zamponi; Vijayaparthasarathi Vijayakumar
Journal:  ACS Omega       Date:  2021-03-31

7.  Targeting of the breast cancer microenvironment with a potent and linkable oxindole based antiangiogenic small molecule.

Authors:  Orestis Argyros; Theodoros Karampelas; Aimilia Varela; Xenophon Asvos; Athanasios Papakyriakou; Adamantia Agalou; Dimitris Beis; Constantinos H Davos; Demosthenes Fokas; Constantin Tamvakopoulos
Journal:  Oncotarget       Date:  2017-06-06

8.  Crystal structure of (1S,4S)-2,5-diazo-niabi-cyclo[2.2.1]heptane dibromide.

Authors:  Sergey N Britvin; Andrey M Rumyantsev
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2017-11-17

9.  Novel Anti-Campylobacter Compounds Identified Using High Throughput Screening of a Pre-selected Enriched Small Molecules Library.

Authors:  Anand Kumar; Mary Drozd; Ruby Pina-Mimbela; Xiulan Xu; Yosra A Helmy; Janet Antwi; James R Fuchs; Corey Nislow; Jillian Templeton; Patrick J Blackall; Gireesh Rajashekara
Journal:  Front Microbiol       Date:  2016-04-06       Impact factor: 5.640

10.  Palladium-Catalyzed Modular Synthesis of Substituted Piperazines and Related Nitrogen Heterocycles.

Authors:  Thomas D Montgomery; Viresh H Rawal
Journal:  Org Lett       Date:  2016-01-29       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.